Kell MR - Search Results

1

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.

O Leary PC, Penny SA, Dolan RT, Kelly CM, Madden SF, Rexhepaj E, Brennan DJ, McCann AH, Pontén F, Uhlén M, Zagozdzon R, Duffy MJ, Kell MR, Jirström K, Gallagher WM. O Leary PC, et al. Among authors: kell mr. BMC Cancer. 2013 Apr 2;13:175. doi: 10.1186/1471-2407-13-175. BMC Cancer. 2013. PMID: 23547718 Free PMC article.

2

Nipple discharge and the efficacy of duct cytology in evaluating breast cancer risk.

Dolan RT, Butler JS, Kell MR, Gorey TF, Stokes MA. Dolan RT, et al. Among authors: kell mr. Surgeon. 2010 Oct;8(5):252-8. doi: 10.1016/j.surge.2010.03.005. Epub 2010 May 13. Surgeon. 2010. PMID: 20709281

3

An imbalance in progenitor cell populations reflects tumour progression in breast cancer primary culture models.

Donatello S, Hudson L, Cottell DC, Blanco A, Aurrekoetxea I, Shelly MJ, Dervan PA, Kell MR, Stokes M, Hill AD, Hopkins AM. Donatello S, et al. Among authors: kell mr. J Exp Clin Cancer Res. 2011 Apr 26;30(1):45. doi: 10.1186/1756-9966-30-45. J Exp Clin Cancer Res. 2011. PMID: 21521500 Free PMC article.

4

Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.

Weiner-Gorzel K, Dempsey E, Milewska M, McGoldrick A, Toh V, Walsh A, Lindsay S, Gubbins L, Cannon A, Sharpe D, O'Sullivan J, Murphy M, Madden SF, Kell M, McCann A, Furlong F. Weiner-Gorzel K, et al. Cancer Med. 2015 May;4(5):745-58. doi: 10.1002/cam4.409. Epub 2015 Feb 15. Cancer Med. 2015. PMID: 25684390 Free PMC article.

5

The fate of chemoresistance in triple negative breast cancer (TNBC).

O'Reilly EA, Gubbins L, Sharma S, Tully R, Guang MH, Weiner-Gorzel K, McCaffrey J, Harrison M, Furlong F, Kell M, McCann A. O'Reilly EA, et al. BBA Clin. 2015 Mar 12;3:257-75. doi: 10.1016/j.bbacli.2015.03.003. eCollection 2015 Jun. BBA Clin. 2015. PMID: 26676166 Free PMC article. Review.

6

Outcome of axillary staging in early breast cancer: a meta-analysis.

Kell MR, Burke JP, Barry M, Morrow M. Kell MR, et al. Breast Cancer Res Treat. 2010 Apr;120(2):441-447. doi: 10.1007/s10549-009-0705-6. Breast Cancer Res Treat. 2010. PMID: 20063121

7

A novel panel of protein biomarkers for predicting response to thalidomide-based therapy in newly diagnosed multiple myeloma patients.

Rajpal R, Dowling P, Meiller J, Clarke C, Murphy WG, O'Connor R, Kell M, Mitsiades C, Richardson P, Anderson KC, Clynes M, O'Gorman P. Rajpal R, et al. Proteomics. 2011 Apr;11(8):1391-402. doi: 10.1002/pmic.201000471. Epub 2011 Feb 25. Proteomics. 2011. PMID: 21365752

8

Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype.

Lowery AJ, Kell MR, Glynn RW, Kerin MJ, Sweeney KJ. Lowery AJ, et al. Among authors: kell mr. Breast Cancer Res Treat. 2012 Jun;133(3):831-41. doi: 10.1007/s10549-011-1891-6. Epub 2011 Dec 7. Breast Cancer Res Treat. 2012. PMID: 22147079 Review.

9

Breast cancer: from Halsted to Harney.

Kell MR. Kell MR. Ir J Med Sci. 2015 Mar;184(1):77-80. doi: 10.1007/s11845-014-1142-z. Epub 2014 Jun 3. Ir J Med Sci. 2015. PMID: 24890450 Review.

10

Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival.

Harris E, Barry M, Kell MR. Harris E, et al. Among authors: kell mr. Ann Surg Oncol. 2013 Sep;20(9):2828-34. doi: 10.1245/s10434-013-2998-2. Epub 2013 May 8. Ann Surg Oncol. 2013. PMID: 23653043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters